{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:54:12Z","timestamp":1790463252772,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.molmed.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T09:46:30Z","timestamp":1510134390000},"page":"1138-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["NEMO Links Nuclear Factor-\u03baB to Human Diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Gunter","family":"Maubach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin","family":"Schm\u00e4dicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2017.10.004_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2017.10.004_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-065X.2012.01101.x","article-title":"DNA damage-dependent NF-\u03baB activation: NEMO turns nuclear signaling inside out","volume":"246","author":"McCool","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2017.10.004_bib0015","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1096\/fj.06-7615rev","article-title":"Beyond I\u03baBs: alternative regulation of NF-\u03baB activity","volume":"21","author":"Neumann","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2017.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/MCB.01538-13","article-title":"Mechanism underlying I\u03baB kinase activation mediated by the linear ubiquitin chain assembly complex","volume":"34","author":"Fujita","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/pde.12103","article-title":"Hypohidrotic ectodermal dysplasia, osteopetrosis, lymphedema, and immunodeficiency in an infant with multiple opportunistic infections","volume":"31","author":"Carlberg","year":"2014","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.245","article-title":"NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II","volume":"7","author":"Pescatore","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2017.10.004_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10875-016-0350-x","article-title":"OL-EDA-ID syndrome: a novel hypomorphic NEMO mutation associated with a severe clinical presentation and transient HLH","volume":"37","author":"Ricci","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0040","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1073\/pnas.1518163113","article-title":"Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-\u03baB activation and autoinflammatory disease","volume":"113","author":"Zilberman-Rudenko","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.10.004_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","article-title":"Deletion of NEMO\/IKK\u03b3 in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma","volume":"11","author":"Luedde","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0050","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/onc.2012.272","article-title":"Requirement of NEMO\/IKK\u03b3 for effective expansion of KRAS-induced precancerous lesions in the pancreas","volume":"32","author":"Maier","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2017.10.004_bib0055","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1038\/onc.2015.400","article-title":"A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization","volume":"35","author":"Nowicka","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2017.10.004_bib0060","doi-asserted-by":"crossref","first-page":"16539","DOI":"10.1074\/jbc.M114.622928","article-title":"Probing the solution structure of I\u03baB kinase (IKK) subunit \u03b3 and its interaction with Kaposi sarcoma-associated herpes virus flice-interacting protein and IKK subunit \u03b2 by EPR spectroscopy","volume":"290","author":"Bagn\u00e9ris","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00276-17","article-title":"Molluscum contagiosum virus MC159 abrogates cIAP1-NEMO interactions and inhibits NEMO polyubiquitination","volume":"91","author":"Biswas","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00545-17","article-title":"Molluscum contagiosum virus protein MC005 inhibits NF-\u03baB activation by targeting NEMO-regulated I\u03baB kinase activation","volume":"91","author":"Brady","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0075","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1128\/JVI.00722-12","article-title":"Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/08830185.2015.1055331","article-title":"EDA-ID and IP, two faces of the same coin: how the same IKBKG\/NEMO mutation affecting the NF-\u03baB pathway can cause immunodeficiency and\/or inflammation","volume":"34","author":"Fusco","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2010.05.012","article-title":"Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB","volume":"396","author":"Shifera","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2017.10.004_bib0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jcp.22105","article-title":"Protein-protein interactions involving IKK\u03b3 (NEMO) that promote the activation of NF-\u03baB","volume":"223","author":"Shifera","year":"2010","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0095","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/MCB.01416-12","article-title":"Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed I\u03baB kinase activation","volume":"33","author":"Blackwell","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","article-title":"Activation of IKK by TNF\u03b1 requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO","volume":"22","author":"Ea","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature09815","article-title":"SHARPIN is a component of the NF-\u03baB-activating linear ubiquitin chain assembly complex","volume":"471","author":"Tokunaga","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2009.03.007","article-title":"Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation","volume":"136","author":"Rahighi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0115","doi-asserted-by":"crossref","first-page":"31728","DOI":"10.1074\/jbc.M113.495846","article-title":"Target Specificity of the E3 Ligase LUBAC for Ubiquitin and NEMO Relies on Different Minimal Requirements","volume":"288","author":"Smit","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0120","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1074\/jbc.M115.640417","article-title":"Polyubiquitin Drives the Molecular Interactions of the NF-\u03baB Essential Modulator (NEMO) by Allosteric Regulation","volume":"290","author":"Catici","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2159-8290.CD-13-0915","article-title":"Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms","volume":"4","author":"Yang","year":"2014","journal-title":"Cancer Dis."},{"key":"10.1016\/j.molmed.2017.10.004_bib0130","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/emboj.2010.300","article-title":"c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling","volume":"29","author":"Dynek","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2017.10.004_bib0135","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/cdd.2017.33","article-title":"Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling","volume":"24","author":"Witt","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2017.10.004_bib0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BJ20140444","article-title":"An unexpected twist to the activation of IKK\u03b2: TAK1 primes IKK\u03b2 for activation by autophosphorylation","volume":"461","author":"Zhang","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2017.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.8096091","article-title":"NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway","volume":"259","author":"Sun","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.10.004_bib0150","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1074\/jbc.M609503200","article-title":"Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I\u03baB kinase activation","volume":"282","author":"Lamothe","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.201307172","article-title":"TNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO\u2013IKK supramolecular structures","volume":"204","author":"Tarantino","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0160","doi-asserted-by":"crossref","first-page":"15247","DOI":"10.1073\/pnas.1314715110","article-title":"Activation of the canonical IKK complex by K63\/M1-linked hybrid ubiquitin chains","volume":"110","author":"Emmerich","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.10.004_bib0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nsmb.2970","article-title":"Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity","volume":"22","author":"Sato","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-\u03baB signalling by deubiquitination","volume":"424","author":"Kovalenko","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0175","doi-asserted-by":"crossref","first-page":"18482","DOI":"10.1074\/jbc.M601502200","article-title":"ABIN-1 Binds to NEMO\/IKK\u03b3 and Co-operates with A20 in Inhibiting NF-\u03baB","volume":"281","author":"Mauro","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","article-title":"OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin","volume":"153","author":"Keusekotten","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tim.2011.08.004","article-title":"Microbial-induced immunomodulation by targeting the NF-\u03baB system","volume":"19","author":"Neish","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ncb2006","article-title":"A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO\/IKK\u03b3 to dampen the host NF-\u03baB-mediated inflammatory response","volume":"12","author":"Ashida","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0195","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/nmicrobiol.2016.84","article-title":"Shigella flexneri suppresses NF-\u03baB activation by inhibiting linear ubiquitin chain ligation","volume":"1","author":"de Jong","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0200","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1073\/pnas.0811058106","article-title":"A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases","volume":"106","author":"Quezada","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.10.004_bib0205","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/1753425910377099","article-title":"The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation","volume":"17","author":"Soundararajan","year":"2011","journal-title":"Innate Immun."},{"key":"10.1016\/j.molmed.2017.10.004_bib0210","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","article-title":"X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production","volume":"203","author":"Filipe-Santos","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2017.10.004_bib0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.22483","article-title":"Insight into IKBKG\/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease","volume":"35","author":"Conte","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2017.10.004_bib0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/humu.20739","article-title":"Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations","volume":"29","author":"Fusco","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2017.10.004_bib0225","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.cdd.4401841","article-title":"NF-\u03baB-related genetic diseases","volume":"13","author":"Courtois","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2017.10.004_bib0230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cge.12223","article-title":"Incontinentia pigmenti diagnostic criteria update","volume":"85","author":"Mini\u0107","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0235","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","article-title":"NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis","volume":"28","author":"Kondylis","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0240","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0377-4929.64291","article-title":"Incontinentia pigmenti","volume":"53","author":"Motamedi","year":"2010","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjo.2009.164434","article-title":"Incontinentia pigmenti \u2013 ophthalmological observation of a series of cases and review of the literature","volume":"95","author":"O\u2019Doherty","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.braindev.2010.04.002","article-title":"Early infantile manifestations of incontinentia pigmenti mimicking acute encephalopathy","volume":"33","author":"Abe","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.molmed.2017.10.004_bib0255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/35013114","article-title":"Genomic rearrangement in NEMO impairs NF-\u03baB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium","volume":"405","author":"Smahi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0260","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/MCB.23.6.2029-2041.2003","article-title":"Tetrameric oligomerization of IkappaB kinase \u03b3 (IKK\u03b3) is obligatory for IKK complex activity and NF-kappaB activation","volume":"23","author":"Tegethoff","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0265","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1038\/ncomms12629","article-title":"Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti","volume":"7","author":"Scholefield","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2017.10.004_bib0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/1346-8138.12091","article-title":"NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients","volume":"40","author":"Okita","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0275","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/hmg\/ddq222","article-title":"Identification of a new NEMO\/TRAF6 interface affected in incontinentia pigmenti pathology","volume":"19","author":"Gautheron","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0280","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddh192","article-title":"Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-\u03baB activation","volume":"13","author":"Fusco","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0285","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.str.2008.02.012","article-title":"Structure of a NEMO\/IKK-associating domain reveals architecture of the interaction site","volume":"16","author":"Rushe","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2017.10.004_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.11.056","article-title":"Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-\u03baB activation and leads to incontinentia pigmenti","author":"Bal","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clim.2015.06.007","article-title":"Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura","volume":"160","author":"Ram\u00edrez-Alejo","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0300","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1525-1470.2010.01261.x","article-title":"Incontinentia pigmenti in a male infant with Klinefelter syndrome: a case report and review of the literature","volume":"27","author":"Buinauskaite","year":"2010","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13353-015-0307-4","article-title":"Molecular basis of hypohidrotic ectodermal dysplasia: an update","volume":"57","author":"Trzeciak","year":"2016","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0310","series-title":"NF-kB in Health and Disease","first-page":"73","article-title":"IKK regulation and human genetics","author":"Courtois","year":"2011"},{"key":"10.1016\/j.molmed.2017.10.004_bib0315","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1242\/dev.128.19.3843","article-title":"Requirement of NF-\u03baB\/Rel for the development of hair follicles and other epidermal appendices","volume":"128","author":"Schmidt-Ullrich","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.molmed.2017.10.004_bib0320","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0325","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00001-11","article-title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I\u03baB\u03b1 deficiency","volume":"24","author":"Picard","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2017.10.004_bib0330","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI0214858","article-title":"Deficient natural killer cell cytotoxicity in patients with IKK-\u03b3\/NEMO mutations","volume":"109","author":"Orange","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2017.10.004_bib0335","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-\u03baB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","article-title":"Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia","volume":"2","author":"Jain","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0345","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2010-10-315234","article-title":"New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein","volume":"118","author":"Hubeau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2017.10.004_bib0350","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1074\/jbc.M510118200","article-title":"A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation","volume":"281","author":"Vinolo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmb.2009.10.018","article-title":"DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding","volume":"395","author":"Grubisha","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0360","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.humpath.2011.08.009","article-title":"NEMO expression in human hepatocellular carcinoma and its association with clinical outcome","volume":"43","author":"Aigelsreiter","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0365","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab2159","article-title":"The hepatitis C virus protein NS3 suppresses TNF-\u03b1-stimulated activation of NF-\u03baB by targeting LUBAC","volume":"8","author":"Chen","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2017.10.004_bib0370","doi-asserted-by":"crossref","first-page":"33161","DOI":"10.1074\/jbc.M114.582478","article-title":"Covalent modification of the NF-\u03baB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro","volume":"289","author":"Hooper","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0375","doi-asserted-by":"crossref","first-page":"18934","DOI":"10.1038\/srep18934","article-title":"Inhibition of canonical NF-\u03baB signaling by a small molecule targeting NEMO-ubiquitin interaction","volume":"6","author":"Vincendeau","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2017.10.004_bib0380","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ncb1458","article-title":"PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress","volume":"8","author":"Mabb","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0385","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.celrep.2013.06.036","article-title":"Innate immune-directed NF-\u03baB signaling requires site-specific NEMO ubiquitination","volume":"4","author":"Jun","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2017.10.004_bib0390","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4049\/jimmunol.179.5.2681","article-title":"Cutting edge: the I\u03baB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis","volume":"179","author":"Shibata","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0395","doi-asserted-by":"crossref","first-page":"54248","DOI":"10.1074\/jbc.M406423200","article-title":"Inhibition of NF-\u03baB activation by peptides targeting NF-\u03baB essential modulator (NEMO) oligomerization","volume":"279","author":"Agou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0400","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.4049\/jimmunol.179.11.7852","article-title":"Amelioration of chronic murine colitis by peptide-mediated transduction of the I\u03baB kinase inhibitor NEMO binding domain peptide","volume":"179","author":"Dave","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0405","doi-asserted-by":"crossref","first-page":"14997","DOI":"10.1002\/anie.201607990","article-title":"A synthetic loop replacement peptide that blocks canonical NF-\u03baB signaling","volume":"55","author":"Bruno","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.molmed.2017.10.004_bib0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095404","article-title":"A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma","volume":"9","author":"Habineza Ndikuyeze","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2017.10.004_bib0415","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/j.1742-4658.2007.05788.x","article-title":"NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex","volume":"274","author":"Fontan","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2017.10.004_bib0420","doi-asserted-by":"crossref","first-page":"17464","DOI":"10.1074\/jbc.M201964200","article-title":"NEMO trimerizes through its coiled-coil C-terminal domain","volume":"277","author":"Agou","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0425","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1158\/1535-7163.MCT-05-0361","article-title":"AGRO100 inhibits activation of nuclear factor-\u03baB (NF-\u03baB) by forming a complex with NF-\u03baB essential modulator (NEMO) and nucleolin","volume":"5","author":"Girvan","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molmed.2017.10.004_bib0430","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2005.23.16_suppl.3064","article-title":"Update on the first phase I study of AGRO100 in advanced cancer","volume":"23","author":"Laber","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0435","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10637-013-0045-6","article-title":"A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma","volume":"32","author":"Rosenberg","year":"2014","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.molmed.2017.10.004_bib0440","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","article-title":"G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms","volume":"1861","author":"Bates","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2017.10.004_bib0445","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","article-title":"Nuclear factor-\u03baB: its role in health and disease","volume":"82","author":"Kumar","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2017.10.004_bib0450","series-title":"GeneReviews(R)","article-title":"Incontinentia pigmenti","author":"Scheuerle","year":"1993"},{"key":"10.1016\/j.molmed.2017.10.004_bib0455","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bmt.2014.157","article-title":"Successful hematopoietic cell transplantation in patients with unique NF-\u03baB essential modulator (NEMO) mutations","volume":"49","author":"Abbott","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.molmed.2017.10.004_bib0460","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2016.01.010","article-title":"Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency","volume":"164","author":"Klemann","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0465","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-03-771600","article-title":"Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations","author":"Miot","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2017.10.004_bib0470","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2008.08.026","article-title":"Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-\u03baB essential modulator deficiency","volume":"122","author":"Pai","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0475","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10875-011-9600-0","article-title":"Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency","volume":"32","author":"Mizukami","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0480","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.10.004_bib0485","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0490","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0495","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nbt.3609","article-title":"Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells","volume":"34","author":"Kim","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0500","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nbt.3620","article-title":"Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells","volume":"34","author":"Kleinstiver","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0505","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.scr.2011.12.007","article-title":"Derivation of human embryonic stem cells with NEMO deficiency","volume":"8","author":"Guan","year":"2012","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.molmed.2017.10.004_bib0510","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.tips.2016.05.008","article-title":"Systematic targeting of protein\u2013protein interactions","volume":"37","author":"Modell","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2017.10.004_bib0515","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drudis.2015.09.011","article-title":"Stabilization of protein\u2013protein interaction complexes through small molecules","volume":"21","author":"Zarzycka","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2017.10.004_bib0520","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/hmg\/ddr556","article-title":"Genomic architecture at the incontinentia pigmenti locus favours de novo pathological alleles through different mechanisms","volume":"21","author":"Fusco","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.10.004_bib0525","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0092-8674(00)81466-X","article-title":"Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-\u03baB activation","volume":"93","author":"Yamaoka","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0530","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-\u03b3 is an essential regulatory subunit of the I\u03baB kinase complex","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0535","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1074-7613(00)80183-1","article-title":"Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKK\u03b3) upon receptor stimulation","volume":"12","author":"Zhang","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2017.10.004_bib0540","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncb1384","article-title":"Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-\u03baB activation [corrected]","volume":"8","author":"Wu","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0545","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.str.2004.07.012","article-title":"The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO\/IKK\u03b3","volume":"12","author":"Saito","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2017.10.004_bib0550","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2012.04.020","article-title":"NEMO ensures signaling specificity of the pleiotropic IKK\u03b2 by directing its kinase activity toward I\u03baB\u03b1","volume":"47","author":"Schr\u00f6felbauer","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0555","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1074\/jbc.M806655200","article-title":"The zinc finger of NEMO is a functional ubiquitin-binding domain","volume":"284","author":"Cordier","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001581","article-title":"A structural basis for I\u03baB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation","volume":"11","author":"Polley","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molmed.2017.10.004_bib0565","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.celrep.2016.10.067","article-title":"Structural basis for the activation of IKK1\/\u03b1","volume":"17","author":"Polley","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2017.10.004_bib0570","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09853","article-title":"Crystal structure of inhibitor of \u03baB kinase \u03b2","volume":"472","author":"Xu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0575","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1074\/jbc.M708856200","article-title":"Phosphorylation of serine 68 in the I\u03baB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-\u03b1-induced NF-\u03baB activity","volume":"283","author":"Palkowitsch","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0580","doi-asserted-by":"crossref","first-page":"24331","DOI":"10.1074\/jbc.M201393200","article-title":"Regulation of I\u03baB kinase (IKK)\u03b3\/NEMO function by IKK\u03b2-mediated phosphorylation","volume":"277","author":"Prajapati","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2017.10.004_bib0585","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1101\/gad.14.7.854","article-title":"Severe liver degeneration and lack of NF-\u03baB activation in NEMO\/IKK\u03b3-deficient mice","volume":"14","author":"Rudolph","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2017.10.004_bib0590","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1097-2765(00)80262-2","article-title":"Female mice heterozygous for IKK\u03b3\/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti","volume":"5","author":"Makris","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0595","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1097-2765(00)80263-4","article-title":"NEMO\/IKK\u03b3-deficient mice model incontinentia pigmenti","volume":"5","author":"Schmidt-Supprian","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2017.10.004_bib0600","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.exer.2008.10.027","article-title":"Preliminary ocular histopathological observations on heterozygous NEMO-deficient mice","volume":"88","author":"Oster","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.molmed.2017.10.004_bib0605","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature05698","article-title":"Epithelial NEMO links innate immunity to chronic intestinal inflammation","volume":"446","author":"Nenci","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.10.004_bib0610","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.immuni.2016.02.020","article-title":"NEMO prevents RIP Kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-\u03baB-dependent and -independent functions","volume":"44","author":"Vlantis","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2017.10.004_bib0615","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/hmg\/ddi470","article-title":"Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling","volume":"15","author":"Nenci","year":"2006","journal-title":"Hum. Mol. Genet."}],"updated-by":[{"DOI":"10.1016\/j.molmed.2018.01.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000}}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417301843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417301843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:15:51Z","timestamp":1761462951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491417301843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":123,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1471491417301843"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2017.10.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NEMO Links Nuclear Factor-\u03baB to Human Diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}